Log in to save to my catalogue

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11172798

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

About this item

Full title

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6243

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Orexin-A is a neuropeptide product of the lateral hypothalamus that acts on two receptors, OX1R and OX2R. The orexinergic system is involved in feeding, sleep, and pressure regulation. Recently, orexin-A levels have been found to be negatively correlated with renal function. Here, we analyzed orexin-A levels as well as the incidence of SNPs in the...

Alternative Titles

Full title

Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11172798

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11172798

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms25116243

How to access this item